Predicted protein targets (top 16)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MEN1 | O00255 | 3/20 | 0.46 |
| ▸ | KMT2A | Q03164 | 3/20 | 0.46 |
| ▸ | SENP5 | Q96HI0 | 5/20 | 0.45 |
| ▸ | SENP2 | Q9HC62 | 5/20 | 0.45 |
| ▸ | SENP1 | Q9P0U3 | 5/20 | 0.45 |
| ▸ | LRRK2 | Q5S007 | 6/20 | 0.45 |
| ▸ | SGMS2 | Q8NHU3 | 1/20 | 0.42 |
| ▸ | NR1H4 | Q96RI1 | 1/20 | 0.42 |
| ▸ | MAOA | P21397 | 1/20 | 0.42 |
| ▸ | MAOB | P27338 | 1/20 | 0.42 |
| ▸ | NPC1 | O15118 | 2/20 | 0.41 |
| ▸ | RAB9A | P51151 | 2/20 | 0.41 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.40 |
| ▸ | MAPT | P10636 | 1/20 | 0.40 |
| ▸ | PKM | P14618 | 1/20 | 0.40 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.40 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL14228206 | 0.87 | SENP5 (0.49) | MEN1KMT2ASENP5SENP2SENP1 | |
| SCHEMBL12779413 | 0.83 | MEN1 (0.47) | MEN1KMT2ASENP5SENP2SENP1 | |
| SCHEMBL14228208 | 0.76 | PTPN1 (0.48) | MAOBALDH1A1MAPTSMN1; SMN2 | |
| SCHEMBL14199904 | 0.72 | MEN1 (0.52) | MEN1KMT2ASGMS2NPC1RAB9A | |
| SCHEMBL23817101 | 0.71 | MEN1 (0.50) | MEN1KMT2ALRRK2SGMS2NR1H4 | |
| SCHEMBL12779412 | 0.70 | SENP5 (0.49) | MEN1KMT2ASENP5SENP2SENP1 | |
| SCHEMBL29951102 | 0.69 | MGLL (0.68) | MAOAMAOBNPC1RAB9AALDH1A1 | |
| SCHEMBL6209756 | 0.69 | MGLL (0.68) | MAOAMAOBNPC1RAB9AALDH1A1 | |
| SCHEMBL14228404 | 0.69 | SMN1; SMN2 (0.47) | MEN1KMT2ANR1H4RAB9AALDH1A1 | |
| SCHEMBL7186209 | 0.68 | KCNK3 (0.71) | MEN1KMT2ANPC1RAB9AALDH1A1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20080097078-A1 | Antibacterial activity against vancomycin-resistant bacteria | SHIONOGI & CO., LTD. (JP) | 2008-04-24 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20080097078-A1 | Antibacterial activity against vancomycin-resistant bacteria | CSGALNACT1, MON2, NR2C2 | MEN1 4301/4885KMT2A 2424/4885SENP5 2454/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.